Other Clinical Trial - A Study Investigating Routine Practice of Chronic

See also
Status	Clinical Trial	Phase
Completed	`NCT04095286` - Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants	Phase 1
Enrolling by invitation	`NCT03683186` - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension	Phase 3
Completed	`NCT02191137` - Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)	Phase 4
Completed	`NCT01959828` - Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery	Phase 3
Withdrawn	`NCT01202045` - Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients	N/A
Completed	`NCT00963027` - Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil	Phase 1
Completed	`NCT00963001` - Effect of Food on the Pharmacokinetics of Oral Treprostinil	Phase 1
Completed	`NCT01121458` - Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed	Phase 4
Terminated	`NCT00825266` - Insulin Resistance in Pulmonary Arterial Hypertension	Phase 4
Terminated	`NCT00384865` - A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension	Phase 2
Active, not recruiting	`NCT03926572` - Acute Decompensation of Pulmonary Hypertension	N/A
Completed	`NCT02826252` - Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)	N/A
Completed	`NCT02545465` - A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice	N/A
Recruiting	`NCT04498299` - Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness
Recruiting	`NCT02558582` - Effect of Exercise Training in Patients With Pulmonary Hypertension	N/A
Active, not recruiting	`NCT02562235` - Riociguat in Children With Pulmonary Arterial Hypertension (PAH)	Phase 3
Completed	`NCT02755298` - Chronic Clinical Effect of Acetazolamide	Phase 2/Phase 3
Completed	`NCT02576002` - Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)	N/A
Terminated	`NCT03043976` - Using Step Count to Enhance Daily Physical Activity in Pulmonary Hypertension	N/A
Completed	`NCT01178073` - A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)	Phase 3

NCT number	NCT02637050
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase
Start date	March 3, 2016
Completion date	September 17, 2020

A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries — EMEA CTEPH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms